Donna Mullahy, PA
Physician Assistant · Niles, ILNPI 1386722783
Payments from drug & device makers
Across 176 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$589
- Johnson & Johnson$372
- Blue Earth Diagnostics$303
- Sumitomo Pharma America, Inc.$231
- Urovant Sciences Inc$213
- Urogen Pharma, Inc.$205
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,60092%
- Education$3008%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 23 | $589 |
| Johnson & Johnson | 22 | $372 |
| Blue Earth Diagnostics | 13 | $303 |
| Sumitomo Pharma America, Inc. | 14 | $231 |
| Urovant Sciences Inc | 6 | $213 |
| Urogen Pharma, Inc. | 8 | $205 |
| AbbVie | 7 | $159 |
| Pfizer | 7 | $130 |
| Procept Biorobotics Corporation | 6 | $129 |
| Verity Pharmaceuticals Inc. | 6 | $126 |
| Bayer | 6 | $123 |
| Merck | 6 | $119 |
| SRS Medical Systems, Inc. | 2 | $104 |
| Dendreon Pharmaceuticals LLC | 3 | $100 |
| Olympus America Inc. | 4 | $94 |
| Accord Healthcare, Inc. | 4 | $82 |
| Endo Pharmaceuticals Inc. | 4 | $66 |
| Endo USA, Inc. | 3 | $63 |
| Convatec Inc. | 3 | $60 |
| Immunitybio, Inc. | 2 | $56 |
| Myovant Sciences Inc. | 2 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
| Tolmar Pharmaceuticals, Inc. | 2 | $47 |
| Boston Scientific | 2 | $46 |
| Progenics Pharmaceuticals, Inc. | 2 | $44 |
| Smith+Nephew | 2 | $39 |
| Laborie Medical Technologies Corp. | 2 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Bluewind Medical | 1 | $31 |
| Dentsply IH Inc. | 1 | $29 |
| Coloplast | 1 | $25 |
| Vertex | 1 | $25 |
| Axonics, Inc. | 1 | $20 |
| Clarus Therapeutics Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $14 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,900 in reported general payments places this provider in the 90th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 117 | $102,535 |
| GemtesaVibegron | 53 | $42,743 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 264 | $7,300 |
| Tamsulosin Hcl | 297 | $5,443 |
| Finasteride | 287 | $4,683 |
| Methenamine Hippurate | 38 | $3,966 |
| Potassium Citrate ErPotassium Citrate | 26 | $2,500 |
| Estradiol | 15 | $1,024 |
| NitrofurantoinNitrofurantoin Macrocrystal | 20 | $987 |
| Dutasteride | 53 | $715 |
| Bethanechol Chloride | 13 | $639 |
| Doxazosin Mesylate | 32 | $493 |
| Testosterone Cypionate | 15 | $449 |
| Allopurinol | 29 | $436 |
| Tolterodine Tartrate | 12 | $416 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $589 | $102,535117 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $231 | $42,74353 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Niles
- Caryn OlshanskyNiles$18K
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.